143PD: Bevacizumab and pemetrexed versus pemetrexed alone as maintenance therapy for patients with advanced nonsquamous NSCLC: Results of the expanded SAKK19/09 trialOliver Gautschi, Adrian F. Ochsenbein, Klazien Matter‐Walstra et al.|Journal of Thoracic Oncology|2016Cited by 0